UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d)
of
The Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported) November
16, 2007
BODISEN
BIOTECH, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
001-32616
|
98-0381367
|
(State
or other Jurisdiction
|
(Commission
File Number)
|
(IRS
Employer
|
of
Incorporation)
|
|
Identification
No.)
|
North
Part of Xinquia Road, Yang Ling Agricultural High-Tech
|
Industries
Demonstration Zone, Yang Ling,
|
People's
Republic of China 712100
|
(Address
of Principal Executive Offices
|
|
86-29-87074957
|
(Registrant’s
Telephone Number, Including Area Code
|
|
Not
Applicable
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General
Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other Events
Press
Release Regarding Ownership of Stock in China Natural Gas
On
November 16, 2007, the Company issued a press release with respect to a lawsuit
filed in the People’s Republic of China relating to the Company’s ownership of
shares in China Natural Gas (CHNG). The press release is attached to this
report
as Exhibit 99.1.
Item
9.01 Financial Statements and Exhibits
(d)
Exhibits
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
release dated November
15, 2007
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
|
|
|
BODISEN
BIOTECH, INC.
|
|
(Registrant)
|
|
|
|
Date: November
16, 2007
|
|
/s/ Bo
Chen
|
|
Bo
Chen
|
|
Chairman,
Chief Executive Officer and President
|